Search

everythinglearnresearchcommunity

for

Search:↓

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Genetic discoveries are leading to new treatments for alopecia areata.

There's no link between low iron levels and the hair loss condition, alopecia areata.

Poor body image from pain can lead to more depression in lupus patients.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Adalimumab helped control a child's severe eye disease when other treatments failed.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

A patient with sickle cell trait and low vitamin D might have lupus, a rare combination that needs more attention.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Ayurvedic treatment, including leech therapy, can effectively regrow hair in alopecia areata.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Skin treatment can lower life quality for patients with skin conditions.

Most Facebook posts about hair loss treatments are promotional and not medically supported, with better quality information found on YouTube.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.